eFFECTOR Therapeutics, Inc. (EFTR) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for EFTR is $5.50, representing a +2,749,900.0% upside from the current price of $0.0002. Price targets range from a low of $1.00 to a high of $10.00.
